Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virology

Development and Evaluation of Fluorogenic TaqMan Reverse Transcriptase PCR Assays for Detection of Dengue Virus Types 1 to 4

Mikako Ito, Tomohiko Takasaki, Ken-Ichiro Yamada, Reiko Nerome, Shigeru Tajima, Ichiro Kurane
Mikako Ito
Department of Virology 1, National Institute of Infectious Diseases, Toyama, Shinjyuku-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiko Takasaki
Department of Virology 1, National Institute of Infectious Diseases, Toyama, Shinjyuku-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken-Ichiro Yamada
Department of Virology 1, National Institute of Infectious Diseases, Toyama, Shinjyuku-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reiko Nerome
Department of Virology 1, National Institute of Infectious Diseases, Toyama, Shinjyuku-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Tajima
Department of Virology 1, National Institute of Infectious Diseases, Toyama, Shinjyuku-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ichiro Kurane
Department of Virology 1, National Institute of Infectious Diseases, Toyama, Shinjyuku-ku, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Kurane@nih.go.jp
DOI: 10.1128/JCM.42.12.5935-5937.2004
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The fluorogenic TaqMan reverse transcriptase PCR (RT-PCR) assay was developed for detecting each of the dengue virus (DV) types 1 to 4. DV genome was detected in all the 35 serum samples from confirmed dengue cases by the TaqMan RT-PCR, although it was not detected in 13 and 21% by conventional type-specific and cross-reactive RT-PCR, respectively.

Dengue virus (DV) infections occur in most tropical and subtropical areas of the world (10). The number of travelers to areas where dengue is endemic has been increasing. Consequently, the number of imported dengue cases has also been increasing. A sensitive and specific assay to detect and discriminate a wide range of isolates of DV types 1 to 4 is needed. A fluorogenic probe-based assay has advantages over the conventional reverse transcriptase PCR (RT-PCR) (1, 3, 7, 8, 15). In the present study, we developed an improved serotype-specific fluorogenic (TaqMan) RT-PCR assay for detecting dengue virus genome. We then examined the newly developed TaqMan RT-PCR for sensitivity and specificity in comparison with conventional RT-PCR, by using serum samples from Japanese dengue patients.

DV types 1, 3, and 4, isolated from Japanese dengue fever patients, were propagated in C6/36 cells. DV type 2, Trinidad strain TR1751, was propagated in suckling mouse brain. West Nile virus, New York and Eg101 strains, Kunjin virus, K47382 and OR393 strains, Japanese encephalitis virus, Gar01 strain, and yellow fever virus, 17D strain, were propagated in Vero cells and used in flavivirus cross-reactivity studies.

One serum sample each was collected from 35 Japanese dengue patients. These patients visited countries where DV was endemic, including India, Sri Lanka, Bangladesh, Thailand, Cambodia, Laos, Singapore, Malaysia, East Timor, Indonesia, the Philippines, Tahiti, and Samoa during the years of 1994 to 2003. Some patients visited more than one country. Of 35 patients, 18 patients were infected with DV type 1, 8 with DV type 2, 6 with DV type 3, and 3 with DV type 4. DV infection was confirmed by immunoglobulin M capture enzyme-linked immunosorbent assay, conventional RT-PCR, or plaque titration assays, as reported by Yamada et al. (21, 22) and Nawa et al. (13).

All the envelope (E) gene nucleotide sequences available in GenBank were retrieved and aligned using CLUSTAL X (version 1.8) (17) to prepare optimized primers and probes for the TaqMan RT-PCR. We used the E gene because it had been best analyzed among dengue genes (2, 4, 5, 6, 9, 14, 16, 18, 19). The strains retrieved from GenBank are shown in Table 1. Primer and probe sequences were selected using the Primer Express software (PE Applied Biosystems, Foster City, Calif.).

Viral RNA was isolated using a QIAamp viral RNA kit (QIAGEN, Valencia, Calif.). The conventional RT-PCR was performed with a TITAN One-Tube RT-PCR kit (Roche Molecular Biochemicals, Indianapolis, Ind.), according to the method of Yamada et al. (21). The cross-reactive and type-specific primers for DV types 1 to 4 were previously reported and evaluated by Morita et al. (11, 12) and Yamada et al. (21) (Table 1). In the TaqMan assay, 5 μl of RNA isolated from a serum sample was mixed with 100 pmol of each primer and 15 pmol of a probe in a 25-μl reaction volume, using a TaqMan RT-PCR Ready-Mix kit (PE Applied Biosystems). The samples were subjected to amplification in an ABI Prism 7000 Sequence Detection System instrument (PE Applied Biosystems). The TaqMan RT-PCR assay consisted of a 30-min RT step at 48°C and 45 cycles of the PCR step (95°C for 15 s and 57°C for 60 s).

PCR products were directly detected by monitoring the increase in fluorescence of a dye-labeled oligonucleotide probe with an ABI Prism 7000 sequence detector. Assay specificity was evaluated by testing serotype-specific probe and primer sets against virus panels that included DV types 1 to 4, West Nile virus (New York strain, 1.0 × 106 PFU/tube; Eg101 strain, 5.4 × 104 PFU/tube), Kunjin virus (K47382 strain, 1.8 × 107 PFU/tube; OR393 strain, 1.6 × 108 PFU/tube), Japanese encephalitis virus (7.6 × 105 PFU/tube), and yellow fever virus (6.0 × 103 PFU/tube). The detection threshold of each TaqMan assay was determined using 10-fold serial dilutions of RNA extracted from stock DV. The threshold was defined as 0.5. This corresponds to the level at which specific viral RNA was consistently detected and at which no nonspecific viral RNA was detected. The threshold cycle value (Ct) was defined as the number of amplification cycles at the threshold. Ct remained within a standard curve having a minimum correlation coefficient of 0.98.

First, the sensitivities of the TaqMan RT-PCR assay for DV types 1 to 4 was evaluated. Reference samples of DV types 1 to 4, which were previously quantified, were diluted 10-fold and used for sensitivity assays. Sensitivities were 1.2 PFU/tube for DV type 1 (Ct = 40.7), 0.1 PFU/tube for type 2 (Ct = 39.2), 1.0 PFU/tube for type 3 (Ct = 38.2), and 0.1 PFU/tube for type 4 (Ct = 38.8). The primer and probe pairs were also tested for virus specificity and did not detect other DV types or other flaviviruses. These results indicate that the newly developed TaqMan RT-PCR assays for DV types 1 to 4 are highly specific.

DV genome was detected in all the 35 serum samples (100%), when tested by the TaqMan RT-PCR. When tested by conventional RT-PCR, DV genome was detected in 27 of 31 serum samples (87%) with type-specific primers and in 26 of 33 samples (79%) with dengue cross-reactive primers (Table 2). These results suggest that sensitivity of TaqMan RT-PCR is higher than those of conventional RT-PCRs (P < 0.02).

We next examined the relationship between virus titers and Ct values by analyzing serum samples from DV type 1-infected patients. There was an inverse correlation between virus titer and Ct (Fig. 1). Additionally, seven serum samples from nondengue patients were tested by TaqMan RT-PCR. DV genome was not detected in any of these samples (data not shown).

We detected DV genome in all the 35 tested serum samples from dengue patients by TaqMan RT-PCR, while 13% (type specific) and 21% (cross-reactive) were determined to be negative by the conventional RT-PCR. The newly developed TaqMan RT-PCR is, therefore, a useful tool for testing acute-phase serum samples from clinically suspected dengue cases. We did not observe any cross-reactions to other dengue types or other flaviviruses. This indicates that the E gene displays a high degree of sequence variation among flaviviruses, which enables us to construct primers and probes with high specificity and sensitivity. To our knowledge, a TaqMan RT-PCR system with a high specificity and high sensitivity has not been reported using other target regions. For example, Warrilow et al. (20) reported a group assay to detect all four dengue serotypes, using the 3′ noncoding region as the target area, but the sensitivity was not high. Callahan et al. also document a group assay with two sets of primers and probes, using the NS5 and C regions as the target area (1). Although they succeeded in detecting the DV types 1 to 4 with a high sensitivity using group assays, they did not obtain high sensitivities in type-specific assays. Additionally, since their group assay requires two sets of primers and probes, its advantage over a type-specific approach is reduced. Furthermore, in contrast to our results, the sensitivity of their type-specific TaqMan assay was not consistent with plaque titration results. Unfortunately, neither we nor Callahan et al. (1) converted the sensitivity units from PFU per milliliter to RNA copies. We will create a stable internal positive control for quantization, using plasmids containing the targeted viral nucleotide sequence, and further standardize the assay in the future.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

A log-scale plot of the virus threshold cycles (Ct) versus the virus titer for dengue virus type 1. Correlation coefficient, 0.502 (6-carboxyfluorescein [FAM] filter).

View this table:
  • View inline
  • View popup
TABLE 1.

Oligonucleotide primers and probes used in the conventional RT-PCR and TaqMan RT-PCR

View this table:
  • View inline
  • View popup
TABLE 2.

Virus gene detection of serum samples from confirmed dengue patients by TaqMan RT-PCR and conventional RT-PCR

ACKNOWLEDGMENTS

We thank the doctors of the clinics and hospitals for providing us with serum samples for laboratory diagnosis of dengue. We also thank David W. Smith, Arbovirus Research and Surveillance Group, Department of Microbiology, University of Western Australia, for providing the initial stock of Kunjin virus (K47382 and OR393 strains).

This work was supported by the grant for the Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour, and Welfare, Japan.

FOOTNOTES

    • Received 10 April 2004.
    • Returned for modification 4 June 2004.
    • Accepted 18 August 2004.
  • Copyright © 2004 American Society for Microbiology

REFERENCES

  1. 1.↵
    Callahan, J. D., S. J. Wu, A. Dion-Schultz, B. E. Mangold, L. F. Peruski, D. M. Watts, K. R. Porter, G. R. Murphy, W. Suharyono, C. C. King, C. G. Hayes, and J. J. Temenak. 2001. Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus. J. Clin. Microbiol.39:4119-4124.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Crill, W. D., and J. T. Roehrig. 2001. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol.75:7769-7773.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Drosten, C., S. Gottig, S. Schilling, M. Asper, M. Panning, H. Schmitz, and S. Gunther. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol.40:2323-2330.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Foster, J. E., S. N. Bennett, H. Vaughan, V. Vorndam, W. O. McMillan, and C. V. Carrington. 2003. Molecular evolution and phylogeny of dengue type 4 virus in the Caribbean. Virology306:126-134.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Goncalvez, A. P., A. A. Escalante, F. H. Pujol, J. E. Ludert, D. Tovar, R. A. Salas, and F. Liprandi. 2002. Diversity and evolution of the envelope gene of dengue virus type 1. Virology303:110-119.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Lanciotti, R. S., D. J. Gubler, and D. W. Trent. 1997. Molecular evolution and phylogeny of dengue-4 viruses. J. Gen. Virol.78:2279-2284.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Lanciotti, R. S., A. J. Kerst, R. S. Nasci, M. S. Godsey, C. J. Mitchell, H. M. Savage, N. Komar, N. A. Panella, B. C. Allen, K. E. Volpe, B. S. Davis, and J. T. Roehrig. 2000. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J. Clin. Microbiol.38:4066-4071.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Laue, T., P. Emmerich, and H. Schmitz. 1999. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J. Clin. Microbiol.37:2543-2547.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Leitmeyer, K. C., D. W. Vaughn, D. M. Watts, R. Salas, I. Villalobos de Chacon, C. Ramos, and R. Rico-Hesse. 1999. Dengue virus structural differences that correlate with pathogenesis. J. Virol.73:4738-4747.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA91:2395-2400.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Morita, K., T. Maemoto, S. Honda, K. Onishi, M. Murata, M. Tanaka, and A. Igarashi. 1994. Rapid detection of virus genome from imported dengue fever and dengue hemorrhagic fever patients by direct polymerase chain reaction. J. Med. Virol.44:54-58.
    OpenUrlPubMedWeb of Science
  12. 12.↵
    Morita, K., M. Tanaka, and A. Igarashi. 1991. Rapid identification of dengue virus serotypes by using polymerase chain reaction. J. Clin. Microbiol.29:2107-2110.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Nawa, M., K. Yamada, T. Takasaki, T. Akatsuka, and I. Kurane. 2000. Serotype-cross-reactive IgM responses in dengue virus infections determined by enzyme-linked immunosorbent assays. Clin. Diagn. Lab. Immunol.7:774-777.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Rico-Hesse, R., L. M. Harrison, R. A. Salas, D. Tovar, A. Nisalak, C. Ramos, J. Boshell, M. T. de Mesa, R. M. Nogueira, and A. T. da Rosa. 1997. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology230:244-251.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Ritchie, S. A., S. Long, G. Smith, A. Pyke, and T. B. Knox. 2004. Entomological investigations in a focus of dengue transmission in Cairns, Queensland, Australia, by using the sticky ovitraps. J. Med. Entomol.41:1-4.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Roehrig, J. T., R. A. Bolin, and R. G. Kelly. 1998. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology246:317-328.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The Clustal X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res.25:4876-4882.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Uzcategui, N. Y., G. Comach, D. Camacho, M. Salcedo, M. Cabello de Quintana, M. Jimenez, G. Sierra, R. Cuello de Uzcategui, W. S. James, S. Turner, E. C. Holmes, and E. A. Gould. 2003. Molecular epidemiology of dengue virus type 3 in Venezuela. J. Gen. Virol.84:1569-1575.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    Wang, E., H. Ni, R. Xu, A. D. Barrett, S. J. Watowich, D. J. Gubler, and S. C. Weaver. 2000. Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J. Virol.74:3227-3234.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Warrilow, D., J. A. Northill, A. Pyke, and G. A. Smith. 2002. Single rapid TaqMan fluorogenic probe based PCR assay that detects all four dengue serotypes. J. Med. Virol.66:524-528.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    Yamada, K., T. Takasaki, M. Nawa, and I. Kurane. 2002. Virus isolation as one of the diagnostic methods for dengue virus infection. J. Clin. Virol.24:203-209.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Yamada, K., T. Takasaki, M. Nawa, S. Yabe, and I. Kurane. 2003. Antibody responses determined for Japanese dengue fever patients by neutralization and hemagglutination inhibition assays demonstrate cross-reactivity between dengue and Japanese encephalitis viruses. Clin. Diagn. Lab. Immunol.10:725-728.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Development and Evaluation of Fluorogenic TaqMan Reverse Transcriptase PCR Assays for Detection of Dengue Virus Types 1 to 4
Mikako Ito, Tomohiko Takasaki, Ken-Ichiro Yamada, Reiko Nerome, Shigeru Tajima, Ichiro Kurane
Journal of Clinical Microbiology Dec 2004, 42 (12) 5935-5937; DOI: 10.1128/JCM.42.12.5935-5937.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Development and Evaluation of Fluorogenic TaqMan Reverse Transcriptase PCR Assays for Detection of Dengue Virus Types 1 to 4
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Development and Evaluation of Fluorogenic TaqMan Reverse Transcriptase PCR Assays for Detection of Dengue Virus Types 1 to 4
Mikako Ito, Tomohiko Takasaki, Ken-Ichiro Yamada, Reiko Nerome, Shigeru Tajima, Ichiro Kurane
Journal of Clinical Microbiology Dec 2004, 42 (12) 5935-5937; DOI: 10.1128/JCM.42.12.5935-5937.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

dengue
dengue virus
Fluorescent Dyes
Reverse Transcriptase Polymerase Chain Reaction
Taq Polymerase

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X